Cargando…

Nutrition and Nonalcoholic Fatty Liver Disease: The Significance of Cholesterol

Nonalcoholic fatty liver disease (NAFLD) is a common chronic liver disease that ranges in severity from simple steatosis to cirrhosis. NAFLD is considered to be associated with hepatic metabolic disorders, resulting in overaccumulation of fatty acids/triglycerides and cholesterol. The pathogenesis a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Enjoji, Munechika, Yasutake, Kenichiro, Kohjima, Motoyuki, Nakamuta, Makoto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3328950/ https://www.ncbi.nlm.nih.gov/pubmed/22550592 http://dx.doi.org/10.1155/2012/925807

Ejemplares similares

Nutrition Therapy for Liver Diseases Based on the Status of Nutritional Intake
por: Yasutake, Kenichiro, et al.
Publicado: (2012)

NPC1L1 inhibitor ezetimibe is a reliable therapeutic agent for non-obese patients with nonalcoholic fatty liver disease
por: Enjoji, Munechika, et al.
Publicado: (2010)

Metabolic Disorders and Steatosis in Patients with Chronic Hepatitis C: Metabolic Strategies for Antiviral Treatments
por: Enjoji, Munechika, et al.
Publicado: (2012)

A new parameter using serum lactate dehydrogenase and alanine aminotransferase level is useful for predicting the prognosis of patients at an early stage of acute liver injury: A retrospective study
por: Kotoh, Kazuhiro, et al.
Publicado: (2008)

NIM811, a nonimmunosuppressive cyclosporine analogue, suppresses collagen production and enhances collagenase activity in hepatic stellate cells
por: Kohjima, Motoyuki, et al.
Publicado: (2007)

Comparison of tissue pressure and ablation time between the LeVeen and cool-tip needle methods
por: Nakamuta, Makoto, et al.
Publicado: (2006)

Early dynamics of viremia in patients with genotype 1b chronic hepatitis C: Peg-IFNα2a shows earlier viral decline than peg-IFNα2b in combination therapy with ribavirin
por: Fujino, Tatsuya, et al.
Publicado: (2011)

A high prevalence of extreme hyperferritinemia in acute hepatitis patients
por: Kotoh, Kazuhiro, et al.
Publicado: (2009)

Transforming Growth Factor‐α Induces the Differentiation of Sarcomatoid Cholangiocarcinoma Cells
por: Enjoji, Munechika, et al.
Publicado: (2000)

Nutritional Genomics in Nonalcoholic Fatty Liver Disease
por: Vasconcellos, Carolina, et al.
Publicado: (2023)

Impact of Nutritional Changes on Nonalcoholic Fatty Liver Disease
por: Perdomo, Carolina M., et al.
Publicado: (2019)

Nutrition and Physical Activity in Nonalcoholic Fatty Liver Disease
por: Oliveira, Claudia P., et al.
Publicado: (2016)

Remnant cholesterol and severity of nonalcoholic fatty liver disease
por: Huang, Hangkai, et al.
Publicado: (2023)

Nonalcoholic fatty liver disease shows significant sex dimorphism
por: Chen, Xing-Yu, et al.
Publicado: (2022)

Dietary and Nutritional Interventions in Nonalcoholic Fatty Liver Disease in Pediatrics
por: Farías, Camila, et al.
Publicado: (2023)

Dietary Anthocyanins as Nutritional Therapy for Nonalcoholic Fatty Liver Disease
por: Valenti, Luca, et al.
Publicado: (2013)

Practical approaches to the nutritional management of nonalcoholic fatty liver disease
por: Freidoony, Leila, et al.
Publicado: (2014)

Intrahepatic microcirculatory disorder, parenchymal hypoxia and NOX4 upregulation result in zonal differences in hepatocyte apoptosis following lipopolysaccharide- and D-galactosamine-induced acute liver failure in rats
por: TANAKA, MASATAKE, et al.
Publicado: (2014)

Nutritional Management of Insulin Resistance in Nonalcoholic Fatty Liver Disease (NAFLD)
por: Conlon, Beth A., et al.
Publicado: (2013)

Significant roles of potential genes and their mutations in nonalcoholic fatty liver disease
por: Sokouti, Babak
Publicado: (2023)

Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020
por: Tokushige, Katsutoshi, et al.
Publicado: (2021)

Ezetimibe: Its Novel Effects on the Prevention and the Treatment of Cholesterol Gallstones and Nonalcoholic Fatty Liver Disease
por: de Bari, Ornella, et al.
Publicado: (2012)

Non-HDL cholesterol and LDL cholesterol in the dyslipidemic classification in patients with nonalcoholic fatty liver disease
por: Du, Tingting, et al.
Publicado: (2017)

Nutritional Approaches for the Management of Nonalcoholic Fatty Liver Disease: An Evidence-Based Review
por: Parra-Vargas, Marcela, et al.
Publicado: (2020)

Total cholesterol to high-density lipoprotein cholesterol ratio is a significant predictor of nonalcoholic fatty liver: Jinchang cohort study
por: Ren, Xiao Yu, et al.
Publicado: (2019)

Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis
por: Lee, Na Young, et al.
Publicado: (2021)

Are Dietary Cholesterol Intake and Serum Cholesterol Levels Related to Nonalcoholic Fatty Liver Disease in Obese Children?
por: Papandreou, Dimitrios, et al.
Publicado: (2012)

Rodent Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
por: Imajo, Kento, et al.
Publicado: (2013)

Sirtuins and nonalcoholic fatty liver disease
por: Nassir, Fatiha, et al.
Publicado: (2016)

History of Nonalcoholic Fatty Liver Disease
por: Lonardo, Amedeo, et al.
Publicado: (2020)

Nonalcoholic fatty liver disease and diabetes
por: Bellini, Maria Irene, et al.
Publicado: (2022)

Can Nutritional Supplements Benefit Patients With Nonalcoholic Steatohepatitis and Nonalcoholic Fatty Liver Disease?
por: Baradeiya, Ahmed M, et al.
Publicado: (2023)

Probiotics and Nonalcoholic Fatty liver Disease
por: Eslamparast, Tannaz, et al.
Publicado: (2013)

Metabolomic characteristics of cholesterol-induced non-obese nonalcoholic fatty liver disease in mice
por: Tu, Lan N., et al.
Publicado: (2017)

The role of hepatic macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
por: Cha, Ji-Young, et al.
Publicado: (2018)

Nonalcoholic fatty liver disease and non-liver comorbidities
por: Manikat, Richie, et al.
Publicado: (2023)

PAR2 controls cholesterol homeostasis and lipid metabolism in nonalcoholic fatty liver disease
por: Rana, Rajashree, et al.
Publicado: (2019)

Sarcopenia Is Significantly Associated with Presence and Severity of Nonalcoholic Fatty Liver Disease
por: Chung, Goh Eun, et al.
Publicado: (2019)

Nonalcoholic Fatty Liver Disease after Liver Transplant
por: Shetty, Akshay, et al.
Publicado: (2021)

Role of Mitochondria in Nonalcoholic Fatty Liver Disease
por: Nassir, Fatiha, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_sgj9f1qfsafji11e8n1flg3054